Event Abstract

Inducible Costimulator (ICOS) facilitates T-dependent B cell differentiation by augmenting IL-4 translation

  • 1 Institut de Recherches Cliniques de Montréal, Canada
  • 2 McGill University, Microbiology and Immunology, Canada
  • 3 Université de Montréal, Médecine, Canada
  • 4 McGill University, Biochemistry, Canada
  • 5 The Rosalind and Morris Goodman Cancer Research Centre, Canada

The Inducible Costimulator (ICOS) is a member of the CD28 family of costimulatory receptor that is highly expressed in follicular helper T cells (Tfh), a subset of CD4 T cells that migrate to the B cell zone and facilitate germinal center reactions. Although ICOS is known to play a critical role in shaping the Tfh cell population during immune reactions, its role in the effector function of Tfh cells has been unclear. Here we demonstrate that ICOS assists TCR-mediated signal transduction by potentiating PI3K-Akt-mTOR signaling cascade that leads to hyperphosphorylation of the key translational regulators p70S6K and 4E-BP1. Consistently, ICOS costimulation promotes the formation of polysomes on IL-4 mRNA in a PI3K-signaling dependent manner. Here we provide evidence that IL-4 production is diminished during T-B cell co-culture when ICOS-PI3K signaling axis is disrupted in T cells. We also show that the 5’ untranslated region of IL-4 mRNA is able to repress the translation of firefly luciferase. Thus, ICOS-PI3K signaling facilitates translation of IL-4 mRNA and this may augment IL-4 production during T-B interaction in germinal centers.

Keywords: ICOS, IL-4, PI3K/AKT/mTOR, translation, costimulation

Conference: 15th International Congress of Immunology (ICI), Milan, Italy, 22 Aug - 27 Aug, 2013.

Presentation Type: Abstract

Topic: Immune receptors and signaling

Citation: Gigoux M, Lovato A, Leconte J, Leung J, Sonenberg N and Suh W (2013). Inducible Costimulator (ICOS) facilitates T-dependent B cell differentiation by augmenting IL-4 translation. Front. Immunol. Conference Abstract: 15th International Congress of Immunology (ICI). doi: 10.3389/conf.fimmu.2013.02.00538

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 10 Jun 2013; Published Online: 22 Aug 2013.

* Correspondence: Mr. Mathieu Gigoux, Institut de Recherches Cliniques de Montréal, Montréal, Canada, Mathieu.Gigoux@ircm.qc.ca